(Press-News.org) The Icahn School of Medicine at Mount Sinai announced the launch of its new Center for Healthcare Readiness, bringing together a diverse team of academic and operational experts to strengthen the Mount Sinai Health System’s strategies and the U.S. health care sector’s capacity to prepare for and respond to any large-scale public health emergency.
The Center will work with both Mount Sinai’s own resources, and public and private partners at the local, regional, and federal levels, to pursue strategies in research, advocacy, innovation, and collaboration to plan for future challenges.
The Center hosted its inaugural “The Future of Healthcare Preparedness Conference” on Wednesday, May 8, bringing together top experts in the field to strategize on how to strengthen health care readiness for the 21st century. Notable speakers from the White House’s Office of Pandemic Preparedness and Response Policy, the U.S. Department of Health and Human Services (HHS), and academia provided insight on emerging priorities across government, health care, and other industries—including pharmaceutical companies, data security, and informational technology—to ensure national health security during major health emergencies.
The conference also addressed opportunities to improve readiness by boosting collaboration among private corporations and the academic sector. The discussion covered a wide range of threats to health security, including emerging pathogens, environmental hazards and their effects on vulnerable populations, importance of preparedness plans and better surveillance programs for new disease threats, improving data sharing capabilities, standardization of data and data interoperability, and military-civilian collaboration.
A keynote panel on “National Priorities for Readiness in the Post-Covid Era” moderated by Brendan Carr, MD, MA, MS, Chief Executive Officer of the Mount Sinai Health System, included Dawn O’Connell, JD, Assistant Secretary for Preparedness and Response within HSS; Maj. Gen. (ret.) Paul Friedrichs, MD, Inaugural Head of the Office of Pandemic Preparedness and Response Policy for the White House; Jeffrey P. Gold, MD, Chancellor of the University of Nebraska Medical Center and member of the President’s COVID-19 Taskforce and the All Hazard 21st Century Threats Taskforce; and Col. (ret.) Robert Kadlec, MD, former Assistant Secretary for Preparedness and Response within HSS. The speakers emphasized the importance of building trust during normal times, collaboration of public and private partners, and regionalization of readiness practice. Other speakers also highlighted the importance of a coordinated approach for health care delivery to ensure optimal outcomes during major public health emergencies and medical disasters.
“Threats to public health remain all around us in the form of cyberattacks, mass shootings, terror attacks, new infectious disease outbreaks, and the effects of climate change. These large-scale events will continue to challenge the nation’s health care sector and other industries,” says Dr. Carr. “In addition to our investment in public health, we must specifically focus on the role of the healthcare sector in caring for the ill and injured. We need robust public-private partnerships in order to ensure that healthcare will always be available to those in need.”
“This Center will harness Mount Sinai’s vast research enterprise, fostering collaboration across medicine including top experts in infectious disease, microbiology, health care services research, education, and informatics to ultimately improve health care delivery for our patients and patients across the country,” says Alexis Zebrowski, PhD, MPH, Co-Director of the Center for Healthcare Readiness and Associate Professor of Emergency Medicine, and Population Health Science and Policy, at Icahn Mount Sinai. “Health care readiness is often thought of in the context of complex and compounding events like the COVID-19 pandemic, but to truly be ready, we have to have the everyday conversations around care delivery. We have to train our next generation of medical professionals and scientists how to think about implementing readiness in everyday practice so that when we need to rely on it, we are already comfortable using the tools, data, and skills.”
The Mount Sinai Center for Healthcare Readiness brings together academic and operational experts in medical research, care delivery, clinical operations, education, and Health System leadership.
“A system-based approach to health care readiness is key to the efforts of the Center. Mount Sinai and other health systems’ roles in a response to a public health emergency must be aligned with the government and public health response, but also, we need to better understand and develop systems and relationships with private industry in an extremely complex health care delivery environment,” says Michael Redlener, MD, Co-Director of Mount Sinai’s Center for Healthcare Readiness and Associate Professor of Emergency Medicine at Icahn Mount Sinai.
Mount Sinai experts will continue to work with national health leaders to address the response to potential public health outbreaks and help build consistent strategies across the United States to deliver high-quality patient care under extreme circumstances. Leaders at the Center will also collaborate with diverse industries, including pharmaceutical and supply chain distributors, to create further consistency in preparedness plans to prevent drug or equipment shortages during major health emergencies.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 48,000 employees working across eight hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it. Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2023-2024. For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
END
Mount Sinai launches Center for Healthcare Readiness to strengthen practice and partnerships in public health emergency response
2024-05-20
ELSE PRESS RELEASES FROM THIS DATE:
Study sheds light on bacteria associated with pre-term birth
2024-05-20
Researchers from North Carolina State University have found that multiple species of Gardnerella, bacteria sometimes associated with bacterial vaginosis (BV) and pre-term birth, can coexist in the same vaginal microbiome. The findings add to the emerging picture of Gardnerella’s effects on human health.
Gardnerella is a group of anaerobic bacteria that are commonly found in the vaginal microbiome. Higher levels of the bacteria are a signature of BV and associated with higher risk of pre-term birth, ...
Evolving market dynamics foster consumer inattention that can lead to risky purchases
2024-05-20
CORVALLIS, Ore. – Researchers have developed a new theory of how changing market conditions can lead large numbers of otherwise cautious consumers to buy risky products such as subprime mortgages, cryptocurrency or even cosmetic surgery procedures.
These changes can occur in categories of products that are generally low risk when they enter the market. As demand increases, more companies may enter the market and try to attract consumers with lower priced versions of the product that carry more risk. If the negative effects of that risk are not immediately noticeable, the market can evolve to keep consumers ignorant of the risks, said Michelle Barnhart, an associate professor ...
Ex-cigarette smokers who vape may be at higher risk for lung cancer
2024-05-20
EMBARGOED UNTIL: 9:15 a.m. PT, May 20, 2024
Session: B20 – Lung Screening: One Size Does Not Fit All
Association of Electronic Cigarette Use After Conventional Smoking Cessation with Lung Cancer Risk: A Nationwide Cohort Study
Date and Time: Monday, May 20, 2024, 9:15 a.m. PT
Location: San Diego Convention Center, Room 30A-B (Upper Level)
ATS 2024, San Diego – Former cigarette smokers who use e-cigarettes or vaping devices may be at higher risk for lung cancer than those who don’t ...
The impacts of climate change on food production
2024-05-20
A new peer-reviewed study from researchers at The University of Texas at Arlington; the University of Nevada, Reno; and Virginia Tech shows that climate change has led to decreased pollen production from plants and less pollen more diversity than previously thought, which could have a significant impact on food production.
“This research is crucial as it examines the long-term impacts of climate change on plant-pollinator interactions,” said Behnaz Balmaki, lead author of the study and an assistant professor of research in biology at UTA. “This study investigates how shifts in flowering times and extreme weather events affect the availability of critical food ...
Mothers live longer as child mortality declines
2024-05-20
ITHACA, N.Y. – The dramatic decline in childhood mortality during the 20th century has added a full year to women’s lives, according to a new study.
“The picture I was building in my mind was to think about what the population of mothers in the U.S. looked like in 1900,” said Matthew Zipple, a Klarman Postdoctoral Fellow in neurobiology and behavior at Cornell University and author of “Reducing Childhood Mortality Extends Mothers’ Lives,” which published May 9 in Scientific Reports.
“It was a population made up of two approximately equal-sized ...
Study reveals promising development in cancer-fighting nanotechnologies
2024-05-20
A new study conducted by the Wilhelm Lab at the University of Oklahoma examines a promising development in biomedical nanoengineering. Published in Advanced Materials, the study explores new findings on the transportation of cancer nanomedicines into solid tumors.
A frequent misconception about many malignant solid tumors is that they are comprised only of cancerous cells. However, solid tumors also include healthy cells, such as immune cells and blood vessels. These blood vessels are nutrient transportation ...
Fat cells influence heart health in Chagas disease
2024-05-20
Jyothi Nagajyothi, Ph.D. and her laboratory at the Hackensack Meridian Center for Discovery and Innovation (CDI) have identified what may be the main mechanism for how chronic Chagas Disease, a parasitic infection affecting millions of people worldwide, can cause irreversible and potentially fatal heart damage.
The culprit is in the adipose (fat tissue) which the parasite Trypanosoma cruzi destroys in the course of infection, releasing smaller particles which induce the dysfunction of heart tissue, conclude the scientists in the journal iScience, a Cell Press open-access journal.
“We are attempting to understand this ...
C-Path’s TRxA announces its first biologics-focused RFP for academic investigators
2024-05-20
TUCSON, Ariz, May 20, 2024 – Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced its inaugural biologics-focused Request for Proposals (RFP) in its Bridging Research and Innovation in Drug Development Grants program (BioBRIDGe). BioBRIDGe awards are designed to help academic researchers traverse the drug development valley of death by providing funding and defining optimal strategies for advancing new, cutting-edge protein-based therapeutics (PBT) from the lab to patients.
For this funding cycle, ...
Enhancing superconductivity of graphene-calcium superconductors
2024-05-20
Superconductors are materials that can conduct electricity with zero resistance when they are cooled below a certain critical temperature. They have applications in several fields, including magnetic resonance imaging, particle accelerators, electric power, and quantum computing. However, their widespread use is limited by the need for extremely low temperatures. Graphene-based materials are promising for superconductors due to their unique properties such as optical transparency, mechanical strength, and flexibility. Graphene is a single layer of carbon (C) atoms arranged in a two-dimensional honeycomb structure. Among these materials, ...
Federal Trade Commission actions on prescription drugs, 2000-2022
2024-05-20
About The Study: The Federal Trade Commission (FTC) brought about one enforcement action and three merger actions per year against pharmaceutical manufacturers from 2000-2022, pursuing a small fraction of the estimated misconduct and consolidation in the pharmaceutical marketplace. Although the FTC faces substantial legal and practical limitations, important tools remain untested, including a rule defining “unfair methods of competition,” that may allow it to more effectively prevent repetitive patterns of anticompetitive behavior.
Corresponding Author: To contact the corresponding author, Aaron S. Kesselheim, ...